MiNK Therapeutics(INKT) - 2023 Q1 - Earnings Call Transcript

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Zack Armen – Head-Investor Relations Jennifer Buell – President and Chief Executive Officer Marc Van Dijk – Chief Scientific Officer Christine Klaskin – Principal Financial and Accounting Officer Conference Call Participants Emily Bodnar – H.C. Wainwright Jack Allen – Baird Matthew Phipps – William Blair Operator Ladies and gentlemen, thank you for standing by. Welcome to the MiNK Therapeutics ...